Rheum Dis Clin North Am 2020 Aug
Risk Factors and Cancer Screening in Myositis.
Related Questions
How would you differentiate new onset inflammatory myositis from paraneoplastic phenomena in a patient with recurrent uterine cancer who is taking aromatase inhibitor?
1 Answers
Mednet Member
Rheumatology · Emory University
Unfortunately, distinguishing whether the patient's dermatomyositis (DM) is "idiopathic" or paraneoplastic the patient with active/recent malignancy is incredibly difficult, if not impossible. While certain myositis-specific autoantibodies (MSA) such as anti-TIF-gamma and anti-NXP-2 are associated w...
If you have clinical suspicion for a paraneoplastic process (e.g. dermatomyositis or pemphigus), what work-up do you pursue?
2
1 AnswersMednet Member
Dermatology · Stanford University
This continues to be a topic of high interest. The first-ever evidence and consensus-based recommendations were recently drafted by an expert international committee under the auspices of the International Myositis Assessment and Clinical Studies (IMACS) group (in preparation). These recommendations...